[8-K] ProPhase Labs, Inc. Reports Material Event

Rhea-AI Filing Summary

ProPhase Labs, Inc. reported that on November 21, 2025 it received written confirmation from Avtech Capital, LLC to continue forbearance under an existing equipment lease. The updated schedule calls for weekly payments beginning November 28, 2025 until all past-due amounts are current, after which the original monthly payment terms under a February 25, 2025 forbearance arrangement will resume.

The company also disclosed that a judgment related to the Avtech equipment lease was entered in Utah on November 5, 2025 and first received by the company on November 19, 2025. ProPhase states this matter is limited to the lease arrangement and does not affect its operations, liquidity, or financial reporting. The most recent Form 10-Q already included required accruals, no restatement is needed, and the company expects to bring the lease current under the updated schedule while continuing to manage contracts in the ordinary course.

false 0000868278 0000868278 2025-11-19 2025-11-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 19, 2025

PROPHASE LABS, INC.

(Exact name of Company as specified in its charter)

Delaware		000-21617		23-2577138
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

626 RXR Plaza, 6th Floor Uniondale, New York		11556
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (516) 903-0763

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14(d)-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered Pursuant to Section 12(b) of the Exchange Act:

Title of Each Class		Trading Symbol		Name of Each Exchange of Which Registered
Common Stock, par value $0.0005		PRHP		Nasdaq Capital Markets

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement

On November 21, 2025, ProPhase Labs, Inc. (the “Company”) received written confirmation from Avtech Capital, LLC (“Avtech”) agreeing to continue its forbearance under the Company’s existing equipment lease. Under Avtech’s updated payment schedule, the Company will make weekly payments beginning November 28, 2025, until outstanding past-due amounts are current. Once current, the original monthly payment schedule under the February 25, 2025, forbearance arrangement will resume.

The Company remains in communication with Avtech regarding these payments, and the written confirmation provides a clear schedule for bringing the lease current. Operations continue in the ordinary course.

Item 8.01 Other Events

On November 5, 2025, a judgment relating to the Avtech equipment lease was entered in Utah. The Company first received the judgment by mail on November 19, 2025. Upon receipt, the Company promptly contacted Avtech and obtained written confirmation on November 21, 2025 that forbearance would continue under the updated schedule described in Item 1.01.

This matter concerns a lease arrangement and does not affect the Company’s operations, liquidity, or financial reporting. The Company’s most recent Form 10-Q accurately reflected all required accruals as of the reporting date, and no restatement is required. The Company has been making payments consistently with its obligations and expects to bring the Avtech lease current within the timeframe set forth in the updated schedule.

Mitigation and Ongoing Activities

The Company continues to review and manage its contractual arrangements in the ordinary course. Management is in communication with counterparties as part of regular planning and may enter into confirmatory amendments, extensions, or similar routine agreements from time to time to support operational continuity. Additional details regarding such matters may be provided in future filings, as appropriate.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

None.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ProPhase Labs, Inc.
By:	/s/ Ted Karkus
Ted Karkus
Chairman of the Board and Chief Executive Officer
Date: November 25, 2025

FAQ

What did ProPhase Labs (PRPH) announce about its Avtech lease?

ProPhase Labs announced it received written confirmation from Avtech Capital, LLC on November 21, 2025 that forbearance under its existing equipment lease will continue under an updated payment schedule.

How will ProPhase Labs (PRPH) repay past-due amounts under the Avtech lease?

Under Avteche28099s updated schedule, ProPhase Labs will make weekly payments beginning November 28, 2025 until all outstanding past-due amounts are current, then return to the original monthly payments under the February 25, 2025 forbearance arrangement.

Was a judgment entered related to ProPhase Labse28099 Avtech lease?

Yes. A judgment relating to the Avtech equipment lease was entered in Utah on November 5, 2025. ProPhase Labs received it by mail on November 19, 2025 and then promptly obtained Avteche28099s written confirmation that forbearance would continue.

Does the Avtech lease judgment affect ProPhase Labse28099 operations or liquidity?

ProPhase Labs states that the judgment and related lease matter do not affect its operations, liquidity, or financial reporting, and that operations continue in the ordinary course.

Is ProPhase Labs (PRPH) changing its prior financial reports because of the Avtech lease?

No. The company states its most recent Form 10-Q accurately reflected all required accruals related to the Avtech lease as of the reporting date and that no restatement is required.

What are ProPhase Labse28099 ongoing plans regarding the Avtech lease?

ProPhase Labs reports it has been making payments consistent with its obligations and expects to bring the Avtech lease current within the timeframe set by the updated schedule, while continuing to manage contractual arrangements in the ordinary course.